Embryo implantation involves complex, programmed interactions among cell surface, extracellular matrix components and growth factor/growth factor receptor-driven processes. Studies from various labs, including the PI's, indicate that heparan sulfate (HS) proteoglycans and HS-binding proteins play key roles at multiple steps of implantation. Important HS-binding proteins include growth factors such as heparin-binding, EGF-like growth factor (HB-EGF), hepatocyte growth factor (HGF) and fibroblast growth factor-2 (FGF-2) as well as HS/heparin interacting protein (HIP/L29), a multifunctional protein identified in the PI's lab as a cell surface component of many epithelial cells and cell lines. HIP/L29 supports blastocyst and cell attachment as well as modulates aspects of the blood coagulation cascade. HIP/29 is highly expressed by uterine epithelia throughout the uterine cycle in both mice and humans. HS-binding growth factors can be released from sites of deposition in the extracellular matrix by the action of heparanase. In this regard, a peptide motif of HIP/L29 has been shown to inhibit heparanase, suggesting that HIP/L29 modulates heparanase-dependent growth factor release. Consistent with this proposal are our recent observations that HIP/L29 or peptides derived from HIP/L29 modulate growth factor activities and cell growth in several systems. Thus, HIP/L29 may play multiple roles in uterine tissues and the fetal-maternal interface including regulation of hemostasis, promotion of cell adhesion and modulation of growth factor activity. In this proposal, we will extend our studies of HIP/L29 function in uterine physiology and implantation using HIP/L29-specific probes, recombinant proteins and molecular genetic approaches in human cell model systems and transgenic mice. We will determine if HIP/L29 modulates the activities of FGF-2, HGF and HB-EGF on cell growth and migration in vitro and to what extent this involves actions at the level of competition for HS binding versus inhibition of heparanase-dependent growth factor mobilization. In addition, we will examine the role(s) that HIP/L29 plays in vivo using transgenic mouse models.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HD025235-18
Application #
6986832
Study Section
Reproductive Biology Study Section (REB)
Program Officer
Yoshinaga, Koji
Project Start
1988-12-01
Project End
2008-04-30
Budget Start
2005-12-01
Budget End
2008-04-30
Support Year
18
Fiscal Year
2006
Total Cost
$298,589
Indirect Cost
Name
University of Delaware
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
059007500
City
Newark
State
DE
Country
United States
Zip Code
19716
Oristian, Daniel S; Sloofman, Laura G; Zhou, Xiaozhou et al. (2009) Ribosomal protein L29/HIP deficiency delays osteogenesis and increases fragility of adult bone in mice. J Orthop Res 27:28-35
Farach-Carson, Mary C; Brown, Anissa J; Lynam, Megan et al. (2008) A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation. Matrix Biol 27:150-60
D'Souza, Sonia; Yang, Weidong; Marchetti, Dario et al. (2008) HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses. J Cell Biochem 105:1183-93
D'Souza, Sonia S; Fazleabas, Asgerally T; Banerjee, Prajna et al. (2008) Decidual heparanase activity is increased during pregnancy in the baboon (Papio anubis) and in in vitro decidualization of human stromal cells. Biol Reprod 78:316-23
Kirn-Safran, Catherine B; D'Souza, Sonia S; Carson, Daniel D (2008) Heparan sulfate proteoglycans and their binding proteins in embryo implantation and placentation. Semin Cell Dev Biol 19:187-93
Farach-Carson, Mary C; Carson, Daniel D (2007) Perlecan--a multifunctional extracellular proteoglycan scaffold. Glycobiology 17:897-905
D'Souza, Sonia S; Daikoku, Takiko; Farach-Carson, Mary C et al. (2007) Heparanase expression and function during early pregnancy in mice. Biol Reprod 77:433-41
Kirn-Safran, Catherine B; Oristian, Daniel S; Focht, Richard J et al. (2007) Global growth deficiencies in mice lacking the ribosomal protein HIP/RPL29. Dev Dyn 236:447-60
Liu, Jian-Jun; Huang, Bao Hua; Zhang, Jinqiu et al. (2006) Repression of HIP/RPL29 expression induces differentiation in colon cancer cells. J Cell Physiol 207:287-92
Liu, Jian-Jun; Zhang, Jinqiu; Ramanan, Sriram et al. (2004) Heparin/heparan sulfate interacting protein plays a role in apoptosis induced by anticancer drugs. Carcinogenesis 25:873-9

Showing the most recent 10 out of 43 publications